Generate QR code
Open Access
Subscription Access
Production of erythropoietin in anemia of various etiology in the elderly
https://doi.org/10.30629/0023-2149-2025-103-8-9-647-653
Abstract
Anemia is a syndrome that often occurs in the elderly and is associated with a poor prognosis. The etiological structure of anemia in the elderly (AE) is diverse. One of the most important pathogenetic mechanisms for the development of anemia of various etiologies is inadequate production of erythropoietin (EPO).
Objective: to determine the prevalence of anemia of various etiologies and the adequacy of EPO production in response to anemia among elderly patients.
Material and methods. A group of 210 patients, the average age was 77.54 ± 8.47 years. The exclusion criteria – malignant neoplasm or oncohematological disease. Etiological factors of AE were defined as iron deficiency (IDA), B12, folic acid, inflammation (ACD), chronic kidney disease (CKD) and their combinations. The adequacy of EPO production was assessed by the ratio of the logarithm of the determined EPO value to the logarithm of the expected EPO value (0/P lg EPO) obtained for the reference group of patients and using covariance analysis.
Results. AE has one cause of development only in 35.2% of cases, in the rest it is a combination of factors. The etiologic structure of AE depending on the leading pathogenetic mechanism: IDA — 9.5%, IDA with CKD — 27%, CKD with GFR less than 60 ml/min/1.73 m2 — 13.8%, CKD with GFR less than 30 ml/min/1.73 m2 —7.6%, B 12 deficiency — 9%, ACD — 14.8%, unexplained anemia of the elderly (UAE) —18%. Inadequate EPO production was observed in the groups of patients with IDA with CKD, CKD, ACD, and UAE; in the groups with IDA and B12-deficient anemia, EPO production was adequate.
Conclusions.The prevalence of UAE depends on the selection criteria. Approximately 2/3 of AE cases are polyetiologic. Due to the polyetiology of AE, it is difficult to accurately divide elderly patients by the etiologic sign of anemia. The cause of inadequate EPO production in AE is CKD and inflammation. Inadequate EPO production is observed already with a decrease in GFR to less than 60 ml/min/1.73 m2.
About the Authors
I. A. Kulikov
Private healthcare institution "Clinical hospital «RZD-Medicine" of the city of Tula»
Россия
Россия
Ivan A. Kulikov — general practitioner, head of the therapeutic department
Tula
V. G. Demikhov
Ryazan State Medical University named after academician I.P. Pavlov, Hematology, Oncology and Immunology Clinic
Россия
Россия
Valery Grigorievich Demikhov — Doctor of Medical Sciences, Professor, Director of the Hematology, Oncology and Immunology Clinic
Ryazan
References
1. Gaskell H., Derry S., Andrew Moore R., McQuay H.J. Prevalence of anaemia in older persons: Systematic review. BMCGeriatr. 2008:8. DOI: 10.1186/1471-2318-8-1
2. Kulikov I.A., Demikhov V.G. The prevalence of anemia and predictors of its development in elderly and senile patients. Bulletin of new Medical Technologies. Electronic edition. 2024;18(4):42–46.(In Russian). DOI: 10.24412/2075-4094-2024-4-1-6
3. Michalak S.S., Rupa-Matysek J., Gil L. Comorbidities, repeated hospitalizations, and age ≥ 80 years as indicators of anemia development in the older population.Ann. Hematol.2018;97(8):1337–1347. DOI: 10.1007/s00277-018-3321-x
4. Schop A. et al. A new diagnostic work-up for defining anemia etiologies: a cohort study in patients ≥ 50 years in general practices. BMC Fam. Pract., 2020;21(1):167. DOI: 10.1186/s12875-020-01241-7
5. Jia W. et al. Anemia in centenarians: prevalence and association with kidney function. Hematol. (United Kingdom). 2020;25(1):26–33. DOI: 10.1080/16078454.2019.1703448
6. Powers J.S. et al. Erythropoietin response to anemia as a function of age. J. Am. Geriatr. Soc.1991;39(1):30–32. DOI: 10.1111/J.1532-5415.1991.TB05902.X
7. Yesayan A.M., Arutyunov G.P., Melikhov O.G. The prevalence of chronic kidney disease among patients who applied to primary health care institutions. The results of a prospective observational study in 12 regions of Russia. Clinical nephrology. 2021;13(3):6–16. (In Russian). DOI: 10.18565/nephrology.2021.3.6-16
8. Clarke R. et al. Vitamin B12 and folate deficiency in later life. Age Ageing. 2004;33(1):34–41. DOI: 10.1093/ageing/afg109
9. Barosi G. Inadequate erythropoietin response to anemia: definition and clinical relevance. Annals of Hematology. 1994;68(5):215–223. DOI: 10.1007/BF01737420
10. Remacha A.F., Bellido M., García-Die F., Marco N., Ubeda J., Gimferrer E. Serum erythropoietin and erythroid activity in vitamin B12 deficiency. Haematologica. 1997;82(1):67–68. URL: https://haematologica.org/article/view/867Accessed: Nov. 03, 2024.
11. MacCiò A., Madeddu C. Management of anemia of inflammation in the elderly. Anemia. 2012. DOI: 10.1155/2012/563251
12. Bregman D.B., Morris D., Koch T.A., He A., Goodnough L.T. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am. J. Hematol.2013;88(2):97–101. DOI: 10.1002/AJH.23354
13. Tavenier J., Leng S.X. Inflammatory pathways to anemia in the frail elderly. Clin. Geriatr. Med. 2019;35(3):339–348. DOI: 10.1016/j.cger.2019.03.005
14. Means R.T. Approach to anemia in the elderly. In: Anemia in the Young and Old: Diagnosis and Management, Springer International Publishing, 2018:27–35.
15. Ershler W.B. Unexplained anemia in the elderly. Clin. Geriatr. Med. 2019;35(3):295–305. DOI: 10.1016/j.cger.2019.03.002
16. Sriram S., Xenocostas A., Lazo-Langner A. Erythropoietin in anemia of unknown etiology: A systematic review and meta-analysis. Hematology. 2016;21(4):234–240. DOI: 10.1080/10245332.2015.1101972
Review
For citations:
Kulikov I.A., Demikhov V.G. Production of erythropoietin in anemia of various etiology in the elderly. Clinical Medicine (Russian Journal). 2025;103(8-9):647-653. (In Russ.) https://doi.org/10.30629/0023-2149-2025-103-8-9-647-653
Views:
28
JATS XML
Email this article 